Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous CONTEPO™ (fosfomycin) for Injection

August 16, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search